Rockwell Medical Inc.
pharmaceutical company
RMTI Nasdaq
ISIN US7743743004 SEC CIK 1041024
Follow Rockwell Medical
Weekly email: filings, results
Revenue, last quarter
$19.1M
+20.1% vs same quarter last year
Net income
−$2.3M
−32.6% vs same quarter last year
EPS, diluted
−$0.59
−1080% vs same quarter last year
Operating cash flow
−$1.5M
−16.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $69.3M | −$5.3M |
| FY24 | $101.5M | −$480K |
| FY23 | $83.6M | −$8.4M |
| FY22 | $72.8M | −$18.7M |
| FY21 | $61.9M | −$32.7M |
| FY20 | $62.2M | −$30.9M |
| FY19 | $61.3M | −$34.1M |
| FY18 | $63.4M | −$32.1M |
| FY17 | $57.3M | −$25.9M |
| FY16 | $53.3M | −$19.8M |
| FY15 | $55.4M | −$14.4M |
| FY14 | $54.2M | −$21.3M |
| FY13 | $52.4M | −$48.8M |
| FY12 | $49.8M | −$54M |
| FY11 | $49M | −$21.4M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 16.9% | −6.8% | −7.7% |
| FY24 | 17.2% | 0.6% | −0.5% |
| FY23 | 10.4% | −8% | −10.1% |
| FY22 | 5.6% | −23% | −25.7% |
| FY21 | −3.9% | −49% | −52.8% |
| FY20 | 4.4% | −45.7% | −49.7% |
| FY19 | 4.6% | −56.3% | −55.7% |
| FY18 | −2.5% | −51.2% | −50.7% |
| FY17 | 6.5% | −45.2% | −45.2% |
| FY16 | 12.7% | −37.9% | −37.2% |
| FY15 | 16.1% | −27.3% | −26.1% |
| FY14 | 15.8% | −32.4% | −39.4% |
| FY13 | 12.7% | −89.8% | −93.1% |
| FY12 | 13.4% | −108.9% | −108.4% |
| FY11 | 11.5% | −44.3% | −43.8% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$1.2M |
| FY24 | $3.2M |
| FY23 | −$9.7M |
| FY22 | - |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
| FY14 | - |
| FY13 | - |
| FY12 | - |
| FY11 | - |
- Rockwell Medical
- Healthcare median
Show the numbers
| Year | Rockwell Medical | Healthcare median |
|---|---|---|
| FY25 | −7.7% | −30.6% |
| FY24 | −0.5% | −47% |
| FY23 | −10.1% | −58% |
| FY22 | −25.7% | −80.4% |
| FY21 | −52.8% | −71.8% |
| FY20 | −49.7% | −62.2% |
| FY19 | −55.7% | −46.2% |
| FY18 | −50.7% | −49.6% |
| FY17 | −45.2% | −45.9% |
| FY16 | −37.2% | −36% |
| FY15 | −26.1% | −37.8% |
| FY14 | −39.4% | −35.5% |
| FY13 | −93.1% | −37.1% |
| FY12 | −108.4% | −29.1% |
| FY11 | −43.8% | −27.9% |